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Loss of E2F7 Expression Is an Early Event in Squamous
Differentiation and Causes Derepression of the Key
Differentiation Activator Sp1
Mehlika Hazar-Rethinam1,3, Sarina R. Cameron1,3, Alison L. Dahler1, Liliana B. Endo-Munoz1, Louise Smith1,
Danny Rickwood1 and Nicholas A. Saunders1,2
Squamous differentiation is controlled by key transcription factors such as Sp1 and E2F. We have previously
shown that E2F1 can suppress transcription of the differentiation-specific gene, transglutaminase type 1 (TG1),
by an indirect mechanism mediated by Sp1. Transient transfection of E2F1–E2F6 indicated that E2F-mediated
reduction of Sp1 transcription was not responsible for E2F-mediated suppression of squamous differentiation.
However, we found that E2F4 and E2F7, but not E2Fs 1, 2, 3, 5, or 6, could suppress the activation of the Sp1
promoter in differentiated keratinocytes (KCs). E2F4-mediated suppression could not be antagonized by E2Fs 1,
2, 3, 5, or 6 and was localized to a region of the human Sp1 promoter spanning 139 to þ 35bp. Chromatin
immunoprecipitation analysis, as well as transient overexpression and short hairpin RNA knockdown
experiments indicate that E2F7 binds to a unique binding site located between 139 and 119bp of the Sp1
promoter, and knockdown of E2F7 in proliferating KCs leads to a derepression of Sp1 expression and the
induction of TG1. In contrast, E2F4 knockdown in proliferating KCs did not alter Sp1 expression. These data
indicate that loss of E2F7 during the initiation of differentiation leads to the derepression of Sp1 and subsequent
transcription of differentiation-specific genes such as TG1.
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INTRODUCTION
Squamous differentiation refers to the process by which
proliferative basal keratinocytes (KCs) irreversibly inhibit
the expression/activity of genes required for proliferation
(for example, cdc2 or E2F1; Jones et al., 1997; Dahler et al.,
1998) and start to induce the expression/activity of genes
required for differentiation (for example, Sp1, transglutami-
nase type 1 (TG1), and involucrin, Eckert et al., 1997;
Eckert et al., 1998; Wong et al., 2003; Wong et al., 2005).
The mechanism by which proliferation and differentiation are
regulated is primarily transcriptional, and a number of
transcription factors (for example, E2F, AP2, Sp1 and Ets)
have been implicated in the control of this process (Eckert
et al., 1997; Eckert et al., 1998; Dicker et al., 2000; Wong
et al., 2003; Wong et al., 2005).
The Sp1 transcription factor family are key regulators of
squamous differentiation, with Sp1, Sp3, and Sp4 all being
expressed by human KCs (Apt et al., 1996; Chen et al., 1997;
Park and Morasso, 1999; Wong et al., 2005). Sp1 is an
activator of squamous differentiation (Apt et al., 1996; Wong
et al., 2005), whereas Sp3 inhibits Sp1-induced squamous
differentiation (Apt et al., 1996; Phillips et al., 2004). For
this reason, it has been speculated that the induction of
differentiation is governed, in part, by the ratio between
activating Sp1 and inhibitory Sp3. For example, Sp1 is
preferentially expressed in differentiated KCs both in vitro
and in vivo (Apt et al., 1996; Wong et al., 2005) and is able
to activate the transcription of differentiation-specific genes
(Wu et al., 1994; Lee et al., 1996; Banks et al., 1998; Jang and
Steinert, 2002). Moreover, transient overexpression of Sp1
in growth-arrested KCs is able to induce the expression
of differentiation-specific markers (Wong et al., 2005). In
contrast, Sp3 is expressed in undifferentiated KCs (Apt et al.,
1996; Wong et al., 2005) and suppresses Sp1-mediated
transcription of differentiation-specific genes (Lania et al.,
1997). Finally, the Sp1/Sp3 ratio is disrupted in differentia-
tion-resistant squamous cell carcinomas (SCC) in vitro and
in vivo, whereas transient overexpression of Sp1 in growth-
arrested SCC cells (induced by E2F inhibition) can induce the
expression of squamous differentiation markers in SCC cells
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(Wong et al., 2005). These data indicate that the induction of
squamous differentiation is associated with an increase in the
expression of Sp1 relative to Sp3.
The E2F family of transcription factors comprise E2Fs 1–8
and can be broadly classified as activating (E2F 1, 2, and 3a)
or inhibitory (E2Fs 3b–8) E2Fs (Johnson and DeGregori, 2006;
DeGregori and Johnson, 2006). Previous studies indicate that
E2F activity stimulates proliferation and suppresses squamous
differentiation (Pierce et al., 1999; Dicker et al., 2000;
Paramio et al., 2000; Wong et al., 2003) in KCs. For example,
it has been shown that inhibition of E2F activity results in the
suppression of proliferation and sensitizes KCs to subse-
quent differentiation stimuli, such as Sp1 (Wong et al., 2005).
Finally, the E2Fs expressed in differentiated KCs also serve to
modulate the expression of differentiation markers (Wong
et al., 2003). In particular, we recently showed that the
inhibitory E2F, E2F7, was preferentially expressed in pro-
liferative KCs and may be involved in the initiation of
squamous differentiation (Endo-Munoz et al., 2009). Thus,
E2F regulation of differentiation appears to be of physiologi-
cal significance and our earlier studies have indicated that the
suppression of the TG1 gene by E2Fs1–5 was indirect in
nature and was mediated by Sp1 (Wong et al., 2003). This
raises the issue of whether E2F-mediated suppression of
squamous differentiation could be mediated by the suppres-
sion of Sp1 expression.
RESULTS
Suppression of Sp1 expression is E2F4 isoform specific
Sp1 mRNA and protein are induced when proliferating
human epidermal KCs (HEKs) are induced to differentiate by
maintaining cells at confluence for 48 hours (Supplementary
Figure S1A and B online). The differentiation status of the
HEK cultures is confirmed by the decrease in the proli-
feration-specific gene, cdc2 (Dahler et al., 1998), and the
induction of the differentiation-specific gene, involucrin
(Crish and Eckert, 2008) (Supplementary Figure S1B online).
The differentiation-specific expression of Sp1 is confirmed in
human skin, in which the proliferation-specific protein,
PCNA, is confined to the basal KCs, whereas involucrin is
localized to the suprabasal KCs (Supplementary Figure S1C
online). The Sp1 transcription factor displayed a nuclear
localization pattern and was more abundant in the suprabasal
layers of the epidermis (Supplementary Figure S1C online).
We transiently overexpressed E2Fs 1–6 in differentiated
KCs and measured the activity of a co-transfected 1.2-kb
fragment of the human Sp1 promoter driving the expression
of a luciferase reporter gene. We found that transient
overexpression of E2F4 and, to a lesser extent, E2F2 could
significantly suppress the SP1-Luc activity, whereas E2Fs 1, 3,
5, and 6 could not (Supplementary Figure S2A online). The
lack of an effect on SP1-Luc activity by E2Fs 1, 3, 5, and 6
was not due to the lack of expression, as the same constructs
(except E2F6 which does not regulate differentiation, Wong
et al., 2004) were all able to suppress differentiation-specific
TG1-Luc activity (Supplementary Figure S2B online). Next,
we showed that E2F4 is expressed in KC nuclei throughout
the epidermis in vivo (Supplementary Figure S2C online).
We tested whether the ability of E2F4 to suppress Sp1-Luc
activity in differentiated KCs could be antagonized by other
E2Fs. Differentiated KCs were co-transfected with sufficient
E2F4 plasmid (0.3 mg) to repress the Sp1 promoter (Figure 1,
lane 2) plus equivalent amounts of expression plasmids
(0.3 mg) coding for individual E2Fs 1–5 or a dominant-
negative form of E2F1 (Dicker et al., 2000), which codes
for the DNA-binding domain and heterodimerization domain
of E2F1 (Figure 1, lanes 3–8). E2Fs 1, 2, 3, 5, and dominant-
negative form of E2F1 did not antagonize, or add to, E2F4-
mediated repression of the Sp1 promoter (Figure 1). In
contrast, transient overexpression of E2F4 further suppressed
E2F4-mediated SP1 promoter repression (Figure 1). These
data indicate that the suppression of the Sp1-Luc promoter
construct is E2F4 selective.
E2F4 suppresses Sp1 transcription via a regulatory region
in the proximal 139 bp of the Sp1 promoter
We co-transfected a deletion series of the human Sp1
promoter–reporter constructs into differentiated KCs with
or without E2F4 (Figure 2). Analysis of the deletion series
indicated that a threefold, E2F4-mediated suppression of
Sp1 transcription was present between 139 and 89 bp
(Figure 2). In contrast, the ability of E2F4 to suppress Sp1
transcription was not present in deletions of 89 bp or less
(Figure 2).
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Figure 1. Suppression of the human SP1 promoter is E2F isoform specific.
Confluent differentiated keratinocytes (KCs) were co-transfected with the SP1-
Luc construct þ either 0.3 mg pcDNA3 or the E2F4 expression plasmid þ
0.3mg of one of E2F1–E2F5 expression plasmids or a dominant-negative form
of E2F1 construct. All transfections were normalized for transfection
efficiency on the basis of b-actin–chloramphenicol acetyl transferase activity.
All data are presented as a percentage of the pcDNA3-transfected control and
are expressed as mean±SEM of triplicate determinations from three
independent experiments. *Po0.05.
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E2F4 and E2F7 repress Sp1 expression in proliferating KCs
E2F7 is an inhibitory E2F that is expressed selectively in
proliferating KCs and is able to modulate differentiation in an
E2F1-independent manner (Endo-Munoz et al., 2009). Con-
sistent with this, data presented in Figure 1 indicates that the
selective suppression of Sp1 by E2F4 is also E2F1 indepen-
dent. Thus, we explored the possibility that E2F7 could also
suppress the Sp1 promoter and that the suppression of the Sp1
promoter, by E2F, may be more physiologically relevant in
the context of the proliferating KC. Transient transfection of
either E2F4 or E2F7b (the major E2F7 transcript in undiffer-
entiated KCs) into differentiated KCs resulted in a statistically
significant suppression of the full-length Sp1 reporter (Figure
3a). Moreover, co-transfection of E2F4þ E2F7b produced an
additive suppression of the Sp1 promoter (Figure 3a). As,
E2F7b is selectively expressed in proliferating KCs (Figure
3b), we hypothesized that the suppression of Sp1 by E2F4
and/or E2F7 may have more physiological relevance in the
context of proliferative/undifferentiated KCs. We examined
the proximal Sp1 promoter region (spanning the 139 to
þ 35 nucleotide region in Figure 2) using a series of
antibodies in chromatin immunoprecipitation (ChIP) assays
on proliferating and confluent/differentiated KCs (Figure 4a).
Figure 4 shows that E2F7 and, to a minor extent, E2F4 and
Sp1 bind to the E2F4/7-responsive region of the Sp1 promoter
in proliferating KCs. Sp1 has been previously reported to
modulate this promoter region in HeLa cells (Nicolas et al.,
2003). Consistent with a loss of E2F7 expression in
differentiated KCs, we observed a significant loss of E2F7
bound to the Sp1 promoter in differentiated KCs while
retaining Sp1 binding (Figure 4a and b). We used the
proximal E2F1 promoter region as a positive control, as it
has been previously shown to bind E2F1 and E2F7 in
proliferation-competent U2OS cells (Di Stefano et al.,
2003). E2F1, 4, 7, and Sp1 bound the E2F1 promoter in
proliferating KCs, whereas only the suppressive E2F4 was
bound to the E2F1 promoter in growth-arrested/differentiated
KCs (Figure 4a).
Co-transfection of proliferative KCs with the Sp1-Luc
reporter plus E2F4 or E2F7b expression plasmids resulted in
the suppression of the Sp1 promoter and Sp1 mRNA
expression (Figure 5a and b). Consistent with this, transient
overexpression of an E2F7 shRNA construct (Endo-Munoz
et al., 2009) derepressed Sp1 promoter activity and Sp1
mRNA, whereas transient overexpression of an E2F4 shRNA
construct (D2, 72% knockdown, see Materials and Methods)
did not (Figure 5a and b). Similar results for different E2F4 or
E2F7 shRNA constructs were obtained (data not shown).
These data suggest that, although E2F4 and E2F7 can repress
Sp1 promoter activity, only E2F7 appears to do so in a
physiologically relevant setting. We examined whether the
transient overexpression of E2F7 shRNA would induce
differentiation-specific genes, TG1 or involucrin. Transient
overexpression of E2F7 shRNA produced a 1.7-fold increase
in TG1 mRNA expression, but failed to induce involucrin
mRNA expression (Figure 5c). Finally, we tested the ability of
the D2 E2F7 shRNA construct to derepress Sp1 transcription
in the HaCaT KC cell line (Figure 5d). Similar to the primary
cultures of HEKs, E2F7b shRNA derepressed Sp1 transcription
in HaCaT cells.
The E2F7-selective repressive site in the Sp1 promoter is,
to our knowledge, previously unreported
The E2F7 responsive site within the Sp1 promoter (139 to
89 bp) did not contain a consensus E2F-binding site, but did
contain AP2- and Sp1-binding sites. Gel shifts with compet-
ing AP2, SP1, or E2F consensus binding sites and supershift
analyses with antibodies against Sp1, Sp3, Sp4, E2F1, E2F4,
E2F7, AP2a, AP2b, and AP2g were all negative (data not
shown). Use of competitor double-stranded DNA regions
indicated that DNA binding to the 139 to 89 bp region
was located between 139 and 119bp (Figure 6a).
Consistent with the E2F7 ChIP data (Figure 4), binding to
the 139 to 119bp region is restricted to proliferating HEKs
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Figure 2. E2F4 suppression of SP1 transcription is mediated via elements
between 139 and 89 bp. Confluent differentiated keratinocytes (KCs) were
co-transfected with a series of Sp1 promoter fragments linked to a luciferase
reporter with either pcDNA3 () or E2F4 (þ ). All transfections were
normalized for transfection efficiency on the basis of b-actin–chloramphenicol
acetyl transferase activity. All data are presented as percentage of the
pcDNA3-transfected control (358 bp construct) and are expressed as
mean±SEM of triplicate determinations from three independent experiments.
The lower panel depicts the same data expressed as a ratio of activity in
controls over activity in the presence of co-transfected E2F4.
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(Figure 6b). Mutation scanning of the 139 to 119bp
region revealed that bases 131 and 130, and 125 and
124 were required for DNA binding in this region
(Supplementary Figure S3A and B online). Mutating the
131 and 130, and 125 and 124 doublet bases, in the
context of Sp1-Luc, resulted in derepression of Sp1-Luc
activity compared with wild-type Sp1-Luc activity in pro-
liferating HEKs (Supplementary Figure S3C online).
DISCUSSION
This study identifies the Sp1 promoter as a physiologically
relevant and specific target of E2F7. This is supported by
several observations. Specifically, E2F7 is preferentially
expressed in proliferating KCs and is preferentially localized
to the E2F repressive region of the Sp1 promoter in
proliferative KCs but not in differentiated KCs. Mutation of
specific bases within the E2F7-sensitive region of the Sp1
promoter derepresses Sp1 transcription. Finally, transient
overexpression of E2F7 shRNA derepresses Sp1 transcription
and expression, resulting in the induction of TG1 transcrip-
tion. In contrast, although E2F4 clearly displayed selectivity
for the Sp1 promoter when overexpressed in differentiated
KCs, it is unlikely to be of physiological relevance as E2F4 is
expressed at similar levels in proliferative and differentiated
KCs in vitro (Paramio et al., 2000; Wong et al., 2003)
and in vivo (Supplementary Figure S2 online). In addition,
E2F4 shRNA does not derepress Sp1 transcription or
expression in proliferating KCs, nor does it induce differ-
entiation markers. Finally, E2F4 bound poorly to the E2F
repressive region of the Sp1 promoter in vivo in both
proliferative and differentiated KCs.
The mechanisms regulating KC proliferation and the
transcriptional induction of differentiation genes have been
extensively studied (Eckert et al., 1997; Eckert et al., 1998). In
this context, we have previously reported that the initiation of
squamous differentiation requires the inhibition of activating
E2Fs (Dicker et al., 2000; Paramio et al., 2000; Wong et al.,
2003). This results in an irreversible growth arrest and the
sensitization of KCs to a subsequent differentiation stimulus,
in part delivered by Sp1 activation (Wong et al., 2003; Endo-
Munoz et al., 2009). We now report that a key event in the
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Figure 3. E2F7 suppresses the SP1 promoter. (a) Confluent/differentiated keratinocytes (KCs) were co-transfected with the Sp1-Luc construct þ either the
E2F4 (0.3þ 0.3mg pcDNA3), E2F7b (0.3þ 0.3 mg pcDNA3), or E2F4þ E2F7b (0.3mg each) expression constructs. All transfections were normalized for
transfection efficiency on the basis of b-actin–chloramphenicol acetyl transferase activity. All data are presented as a percentage of the pcDNA3-transfected
control and are expressed as mean±SEM of triplicate determinations from three independent experiments. (b) RNA was harvested from proliferative or
confluent/differentiated KCs and E2F7b mRNA expression determined by quantitative RT-PCR. Data presented as mean±SEM from triplicate determinations
from two independent experiments. *Po0.05.
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Figure 4. E2F7 is selectively bound to the human Sp1 promoter in proliferative
keratinocytes (KCs). (a) Extracts were from proliferative (Prol.) or confluent/
differentiated (Confl.) human KCs prepared for chromatin immuno-
precipitation (ChIP) analysis. Extracts were incubated with antibodies against
Sp1, E2F4, E2F7, E2F1, or IgG. ChIP-enriched fractions were then examined
for the presence of Sp1 or E2F1 promoter sequences by PCR. In total, 10% of
the input extract was used as a positive control. A representative experiment is
shown. (b) The ratio of Sp1 promoter amplified from the ChIP extracts over the
amount of Sp1 promoter amplified from the input is shown for triplicate
determinations from two independent experiments. Data shown as
mean±SEM.
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initiation of differentiation is the loss of E2F7 expression,
which results in the derepression of the differentiation-
inducing transcription factor, Sp1 (Supplementary Figure S4
online). Specifically, when KCs receive a stimulus to
differentiate (for example, protein kinase C activation or
confluence), they inhibit the activity of activating E2Fs (Jones
et al., 1997; Paramio et al., 2000) resulting in a growth arrest.
As E2F7 expression is transcriptionally regulated by activating
E2Fs such as, E2F1 (Di Stefano et al., 2003; de Bruin et al.,
2003), the induction of growth arrest is also accompanied by
the loss of E2F7 expression, resulting in the derepression of
Sp1 expression and the potential activation of elements of the
squamous differentiation program (Supplementary Figure S4
online).
The data from this study, and the work of others, would
suggest that, although Sp1 is a key differentiation factor, the
induction of Sp1 alone may not be sufficient to induce a
complete squamous differentiation program. For example,
although Sp1 is required for the transcription of a variety of
squamous differentiation-specific genes (for example, TG1
and involucrin) the differentiation-specific expression of
these genes, in truth, is controlled by the combinatorial
action of multiple transcription factors such as Sp1, AP2,
Fra-1, POU2F3, FOXQ1, CREBP, Ets, or AP1 (Medvedev
et al., 1999; Popa et al., 2004; Crish and Eckert, 2008; Sen
et al., 2009). Moreover, derepression of Sp1, following E2F7
knockdown, resulted in an induction of TG1, but not of
involucrin, in proliferating human KCs. Thus, Sp1 may be
sufficient for the activation of a subset of differentiation
genes, but it is not sufficient for the activation of the complete
program of squamous differentiation. This is consistent with a
recent report in which it was shown that activation of a subset
of squamous differentiation genes could be initiated by
demethylase-mediated derepression of key differentiation
factors such as POU2F3 (Skn-1a) or FOXQ1 (Sen et al.,
2009). Our findings combined with those of Sen et al. (2009)
indicate that derepression of key differentiation-inducing
factors by either transcriptional or epigenetic means may be a
central regulatory event in the initiation of squamous
differentiation.
The suppression of Sp1 transcription by E2F7 may explain
why SCCs are insensitive to differentiation stimuli. Similar to
most tumors, SCCs have a disrupted E2F:Rb axis character-
ized by constitutive activation of activating E2Fs, such as
E2F1, resulting in the activation of E2F1 transcription (Dicker
et al., 2000; Endo-Munoz et al., 2009). This in turn causes an
induction of E2F7 transcription (Li et al., 2008; Zalmas et al.,
2008; Endo-Munoz et al., 2009). The increase in E2F1 and
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Figure 5. E2F7 is a physiologically relevant repressor of the Sp1 promoter. Proliferating keratinocytes (KCs) were co-transfected with green fluorescent protein
(GFP) plasmid combined with pCDNA3 (Control) or an E2F4, E2F7b, E2F4 shRNA, or E2F7 shRNA expression plasmid. (a) KCs were also co-transfected with the
SP1-Luc construct þ b-actin–chloramphenicol acetyl transferase reporters. (b) Transfected cells were enriched for GFP positivity by Moflo and assessed for SP1
mRNA, or (c) E2F7 shRNA (þ ) or vector control () transfected keratinocytes were assayed for TG1 and involucrin mRNA expression. (d) Proliferating HaCaT
cells were co-transfected with Sp1-Luc þ b-actin Cat þ either pcDNA3 (Control) or E2F7 shRNA (D1 construct shown). Sp1-Luc activity was measured and
normalized against b-actin–chloramphenicol acetyl transferase activity. Data are expressed as mean percent control±SEM of triplicate determinations from
three experiments. *Po0.05.
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E2F7 expression would be predicted to render the SCCs
insensitive to normal differentiation stimuli, leading to the
continued repression of the Sp1 promoter by E2F7, even in
the presence of a differentiation stimulus. Such a model is
consistent with previous reports that SCCs and SCC cell lines
are characterized by an unchanging Sp1/Sp3 ratio in response
to a differentiation stimulus (Wong et al., 2005). This is
also supported by data showing that transient overexpression
of Sp1 in SCCs can induce differentiation markers in growth-
inhibited SCC cell lines (Wong et al., 2005).
The molecular basis for E2F4 and E2F7 selective repres-
sion of the SP1 promoter involves a, to our knowledge,
previously unreported, mechanism. In general, E2F family
members exhibit similarity in their transcriptional targets (Kel
et al., 2001; Muller et al., 2001). However, some reports have
emerged showing that various E2F isoforms can bind
selective genes (Kel et al., 2001; Muller et al., 2001). In
particular, Araki et al. (2003) showed that E2F4 selectively
bound the 50-TTTCGCGGCAAA-30 element within the E2F1
promoter, whereas E2F1 and E2F3 bound the 50-TTTG
GCGCGTAAA-30 element of the same promoter during cell
cycle traverse. However, in the studies of Araki et al. (2003)
the E2F4-selective and E2F1/3-selective elements still con-
form to a consensus E2F-binding site (50-TTTSGGCSMDR-30;
Kel et al., 2001). In this study, we found the SP1 promoter to
be E2F7 and E2F4 responsive. However, we were unable to
show that E2F1 binds the SP1 promoter or that E2F1, 2, 3, or 5
were able to modulate SP1 promoter activity. This is
consistent with the lack of consensus E2F-binding sites (50-TT
TSGGCSMDR-30; Kel et al., 2001) within the 139 to 89 bp
region of the SP1 promoter. As E2F7 is known to bind
consensus E2F elements within the E2F1 promoter, yet E2F7,
but not E2F1, bound and repressed the Sp1 promoter in
KCs, it is clear that the E2F7-responsive region within the
SP1 promoter (50-CTCCTTTCCCCCTCCCTCAT-30) is, to our
knowledge, previously unreported, and differs to the pub-
lished E2F consensus sequence (Note: underlined nucleotides
refer to identified essential binding elements in Supplemen-
tary Figure S3 online). However, although our ChIP analysis
indicated that E2F7 binds the Sp1 promoter and our mutation
analysis indicated that mutation of specific bases within the
region resulted in the derepression of Sp1 transcription, we
did not determine whether E2F7 bound the DNA directly or
whether E2F7 binding was mediated via interacting partner
protein(s).
MATERIALS AND METHODS
Tissue culture of epidermal KCs
Isolation and culture of normal HEKs from neonatal foreskins have
been described elsewhere (Jones et al., 1997). Briefly, HEK cultures
were grown and maintained in low-calcium (0.05mM Ca2þ final
concentration) serum-free KC culture medium (Invitrogen, Sydney,
NSW, Australia). Culture of HaCat cells was as described before
(Dicker et al., 2000). Subconfluent cultures of early passage (passage
2–3) HEKs were collected when proliferative cells were required.
HEK cultures maintained at confluence for at least 48 hours were
collected when growth-arrested, differentiated KCs were required
(Dicker et al., 2000).
Protein isolation and western blotting
Total cellular protein was collected and quantified as described
(Brinkmann et al., 2001). Protein (5 mg) was then electrophoresed on
either a 10 or 7.5% SDS-PAGE gel and transferred onto poly-
vinylidene difluoride membrane (Brinkmann et al., 2001). Immuno-
detection of cdc2 (1:1,000; Ab-1, PC25; Oncogene Science,
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Figure 6. DNA binding to the E2F7 responsive site is restricted to 139 and
119 bp in the human Sp1 promoter. Nuclear extracts (NE) from human
epidermal keratinocytes (HEKs) were prepared and incubated with 32P-
labeled fragment of double-strand DNA corresponding to the 139 to 89 bp
region of the human Sp1 promoter and subjected to electromobility shift
assays, as described in Supplementary Figure S3 online. (a) Specific DNA-
binding complexes are shown (arrows). Competition with double-strand
oligonucleotides corresponding to pieces of the 139 to 89 bp region and
competition with an unrelated double-strand oligonucleotide (Non-sp) are
shown. (b) Nuclear extracts from proliferative (Prol.) or confluent/
differentiated (Diff.) HEKs were incubated with 32P-labeled probe as in a.
Representative gel shifts from three independent experiments are shown.
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Cambridge, MA), involucrin (1:1,000; Sigma-Aldrich, Sydney, NSW,
Australia; I-9018), or Sp1 (1:1,000; 07-124; Upstate Biotechnology,
Sydney, NSW, Australia) were performed and visualized by standard
techniques (Dahler et al., 1998; Serewko et al., 2002; Wong et al.,
2005).
ChIP assays
HEKs were trypsinized and ChIP was performed for IgG, E2F1, E2F4,
and Sp1, as previously described (Wong et al., 2005). In addition,
ChIP assays were also performed using an anti-E2F7 antibody (2mg
per sample, sc-66870, Santa Cruz Biotechnology, Santa Cruz, CA).
Primers for the amplification of the human E2F7 (125 bp product)
and Sp1 promoters (174 bp product) were as follows: E2F7 forward
primer 50-AGGAACCGCCGCCGTTGTTCCCGT-30, reverse primer
50-GCTGCCTGCAAAGTCCCGGCCACT-30 (Zalmas et al., 2008),
Sp1 forward primer 50-ATATATACGCGTTAGGTTGGGCTTGTGG
CG-30, reverse primer 50-ATATATCTCGAGTGGCAGCTGAGGGA
CAAG-30. In all instances, an IgG negative control and a positive
control (10% of the input cellular extract) were analyzed at the same
time. Promoter fragments were amplified for 35 cycles and then run
on a 1.8% agarose gel. Quantitation of ChIP data for the Sp1
promoter studies was estimated by comparing the amount of Sp1
promoter PCR product in the ChIP extract relative to the same
product present in the ‘‘Input’’.
RNA isolation and RT-PCR
The isolation of RNA and the preparation of single-strand cDNA has
been described (Walshe et al., 2007). Estimation of actin, E2F4, TG1,
involucrin, Sp1, and E2F7 mRNA expression was performed by
real-time quantitative PCR (Endo-Munoz et al., 2009; Walshe et al.,
2007). The primer sequences for Sp1 and E2F4 are as follows: Sp1
forward 50-CAAAAAGAAGGAGAGCAAAA-30, reverse 50-GATGG
CTTGAGTTGTAAAGG-30, E2F4 quantitative RT-PCR primer
targeting p107/p130 binding was purchased from SABiosciences
(Frederick, MD) (PPH00362E-200).
Immunohistochemistry
Immunohistochemistry was performed on formaldehyde-fixed
paraffin-embedded sections of human skin (Serewko et al., 2002;
Wong et al., 2005). Human skin was collected in accordance with
the institutional ethics committee (Princess Alexandra Hospital).
Immunohistochemical detection of E2F4 (1:500; sc-866, Santa Cruz)
used similar methodology as for Sp1 (Wong et al., 2005).
Promoter cloning, transfection, and reporter assays
A fragment comprising 1.549Kb to þ 35 bp of the human Sp1 gene
(Nicolas et al., 2001) was generated by amplification from human
genomic DNA and directionally cloned into the PGL2 basic
promoter construct (Promega, Sydney, NSW, Australia). From this,
were generated a series of sequence-verified Sp1 promoter deletions,
by PCR amplification, spanning 1549 bp (Sp1-Luc), 1183, 721,
358, 239, 186, 139, 89, and 39 bp. In addition, we
introduced a scanning series of two base mutations into the 139 to
119bp region of the Sp1-Luc construct using a PCR-based method
(Finnzymes, no. F-541; Genesearch, Arundel, Queensland, Austra-
lia). Transfection protocols, and luciferase and chloramphenicol
acetyl transferase reporter assays have been described (Wong et al.,
2003). All transfections are normalized for transfection efficiency by
reference to co-transfected b-actin–chloramphenicol acetyl transfer-
ase promoter activity.
Overexpression, shRNA knockdown, and sorting
Expression plasmids for E2F4 and E2F7b have been described (Wong
et al., 2003; Endo-Munoz et al., 2009). E2F7 shRNA expression
plasmids and knockdown efficiency have been described previ-
ously (Endo-Munoz et al., 2009). shRNA clones against E2F4 and
expressing green fluorescent protein were purchased from SABios-
ciences. shRNA constructs tested (D1–D4) knocked down E2F4
mRNA expression in KCs to 54±4, 28±2, 96±9, and 47±2%
of shRNA control-transfected KCs, respectively. In the instance
of the E2F4 and E2F7 overexpression plasmids, the KCs were co-
transfected with a green fluorescent protein expression plasmid
(Smith et al., 2004). Transfected cells were isolated by flow
cytometry 48 hours after transfection (Endo-Munoz et al., 2009)
based on green fluorescent protein expression.
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